Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral drug delivery market is a $35 billion industry and expected to grow as much as ten percent per year.

Kalorama’s Drug Delivery Markets: Oral Delivery provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.

In the reporting of market size and growth through 2013, Kalorama’s unique analysis breaks out separates the value of the technology portion of the market from the active ingriedient portion of the market, allowing for a deeper understanding of the value of the market attributable to the delivery technologies themselves.

This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Legacy Companies in Oral Delivery as well as Recent Entrants
• Current World Wide Revenue Across Product Categories and Future Forecasts
• Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other)
• Challenges Faced by Oral-Delivery Technology Companies
• Success Stories and Pitfalls
• The Trends That are Expected to Lead to Global Growth

Kalorama’s trusted information-gathering process provides most accurate study of the oral delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.

Related Reports:

Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
Sep 1, 2009 - KLI2422083 - $2,995.00

World Market for Respiratory Equipment and Disposables, 3rd. Edition
Aug 1, 2008 - KLI1676679 - $2,995.00

Pharmaceutical Excipients for Oral Formulations, 2nd. Edition
Feb 1, 2008 - KLI1517793 - $2,500.00

Anesthesia Drugs: Worldwide Markets
Jul 1, 2007 - KLI1399472 - $2,500.00

Drug Delivery Series I-IV (Oral, Implantable/Injectable, Pulmonary and Transdermal/Transmucosal Systems)
Apr 1, 2007 - KLI1467004 - $4,995.00

Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery
Apr 1, 2007 - KLI1399450 - $2,495.00

Drug Delivery Markets, Vol III: Pulmonary Delivery Systems
Mar 1, 2007 - KLI1399440 - $2,495.00

Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems (Markets for Needle-Free, Targeted Injectable, Sustained-Release Implantable and Other Systems)
Feb 1, 2007 - KLI1375771 - $2,995.00

The World Market for Pain Management Drugs and Devices, 2nd Edition
Dec 1, 2006 - KLI1190856 - $3,500.00

The World Market for Prescription Respiratory Drugs
Oct 1, 2006 - KLI1190854 - $3,500.00